Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,595.50
Bid: 1,595.00
Ask: 1,596.00
Change: -22.50 (-1.39%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,594.50
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TREASURIES-Yields lower, curve flatter ahead of Fed

Fri, 11th Dec 2020 21:23

(New throughout)
By Kate Duguid
NEW YORK, Dec 11 (Reuters) - A risk-off move drove Treasury
yields down across maturities on Friday, with the two-year yield
falling to a four-month low, furthering speculation that the
Federal Reserve may announce adjustments to its Treasury
purchases at next week's meeting.
The fall in yields was partly attributable to reports that
congressional wrangling over a spending package and coronavirus
aid could drag on through Christmas. Also pulling yields lower
was news that European pharmaceutical companies Sanofi SA
and GlaxoSmithKline Plc would delay the launch
of their COVID-19 vaccine until late next year, a setback in the
global fight against the pandemic.
Those macroeconomic drivers explain the fall in the
benchmark 10-year yield and the 30-year bond yield
to their lowest since Dec. 1. In afternoon trade,
both had pulled back from those lows, with the 10-year last down
1.5 basis points at 0.892% and the 30-year down 1.4 basis points
at 1.622%.
The move in the two-year yield to its lowest
since Aug. 7, however, was surprising, as the yield has been
roughly anchored since the Fed moved interest rates to zero at
the beginning of the pandemic. It was last down 2 basis points
at 0.119%.
Analysts argued the two-year move was likely not purely the
result of macroeconomic drivers. Yields on Treasury bills - debt
with a maturity of one year or less - are all less than 10 basis
points away from 0%, according to Tradeweb data.
"The idea that bills could potentially go to zero is taking
twos, threes and fives along with it," said Justin Lederer,
Treasury analyst and trader at Cantor Fitzgerald.
Since the lows hit in March, the 10-year yield has risen
more than 60 basis points, and the 30-year has risen nearly 100.
The two-year yield, by comparison, was just a basis point and a
half higher than the all-time low it hit in May.
Both long rates have increased enough in the past several
months that some analysts believe the Fed will purchase more
longer-dated debt to cap yields and keep borrowing costs low.
Since March the Fed has bought more than $2 trillion worth of
Treasury debt, most of it in shorter-dated notes.
If the Fed were to lengthen the average maturity of its
Treasury holdings - by purchasing the same amount but buying
more longer-dated debt and less shorter-dated debt - it could
also have the effect of bolstering Treasury bills and
shorter-dated notes away from zero.
"I can see the Fed trying to do something to alleviate that.
They definitely don't want bills trading negative, or repo
trading negative," said Lederer.

December 11 Friday 4:14PM New York / 2114 GMT
Price Current Net
Yield % Change
(bps)
Three-month bills 0.0725 0.0735 -0.006
Six-month bills 0.0825 0.0837 0.000
Two-year note 100-3/256 0.119 -0.020
Three-year note 99-216/256 0.1772 -0.019
Five-year note 100-16/256 0.3623 -0.021
Seven-year note 100 0.625 -0.021
10-year note 99-212/256 0.8931 -0.015
20-year bond 99-76/256 1.4156 -0.016
30-year bond 100-12/256 1.623 -0.013

DOLLAR SWAP SPREADS
Last (bps) Net
Change
(bps)
U.S. 2-year dollar swap 7.50 0.25
spread
U.S. 3-year dollar swap 6.00 0.00
spread
U.S. 5-year dollar swap 5.50 0.00
spread
U.S. 10-year dollar swap -1.00 -0.50
spread
U.S. 30-year dollar swap -29.00 -1.00
spread


(Reporting by Kate Duguid; Editing by Ken Ferris and Jonathan
Oatis)

More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.